IMU 0.00% 10.5¢ imugene limited

Thoughts ? Reads well..... Imugene lead product HER-Vaxx patent...

  1. 2,204 Posts.
    lightbulb Created with Sketch. 208
    Thoughts ? Reads well.....
    Imugene lead product HER-Vaxx patent application receives US Notice of Allowance • Imugene’s biggest intellectual property milestone • Patent will give method of composition and method of use protection to 2030 Melbourne, 29 July 2014: Australian biopharmaceutical company Imugene Limited (ASX:IMU) has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for Patent Application 13/389419 (2030 expiry) which protects its HER-Vaxx cancer immunotherapy, currently in development for gastric cancer. The patent titled “Multiepitope Vaccine for HER2/Neu-associated Cancers” protects the method of composition and method of use of Imugene’s HER-Vaxx for the generation of a therapeutic antibody response against HER-2/neu. HER-Vaxx is a proprietary therapeutic cancer immunotherapy that stimulates a polyclonal antibody response to HER-2/neu, the same biomarker targeted by the $US6.9 billion per annum drug Herceptin®. HER-Vaxx has successfully completed a Phase 1 study in breast cancer and the next stage of development will be a Phase 2 study in gastric cancer. Dr Nick Ede, Executive Director Imugene said, “Attaining the key US patent is the biggest milestone for almost every biotechnology company. This adds extra value to HER-Vaxx as this will protect it in the world’s largest pharmaceutical market until 2030.” Gastric or stomach cancer is the second most common cause of cancer-related death in the world and the fourth most commonly diagnosed cancer, with over 1,000,000 new cases diagnosed each year. Contact : Paul A Hopper Dr Nick Ede Executive Chairman Executive Director +1 858 334 5820 (US) +61 400 642 254 +61 406 671 515 (Australia) nede[at]imugene.com receptogen[at]earthlink.net Media contact:
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
176 10004604 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 420568 8
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 28/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.